Mertansine Options
Pharmacological inhibition from the ataxia telangiectasia and Rad3-linked protein serine/threonine kinase (ATR; also known as FRAP-linked protein (FRP1)) has emerged being a promising technique for most cancers treatment that exploits synthetic lethal interactions with proteins associated with DNA damage repair service, overcomes resistance to othe